Mineralys Therapeutics prices upsized $250M stock offering

2 days ago 2

Mineralys Therapeutics (NASDAQ:MLYS) priced an upsized underwritten public offering of 9.8M shares at a public offering price of $25.50 per share.
The aggregate gross proceeds to Mineralys from the offering are expected to be approximately $250.0 million.
Underwriters have a